AOTI announces US FDA 510(k) Clearance for an extension of the indications for their NEXATM NPWT System. The amended indications, "for use in acute, extended and home care settings…," will allow the device to be marketed to additional care...
AOTI announces US FDA 510(k) Clearance for an extension of the indications for their NEXATM NPWT System. The amended indications, "for use in acute, extended and home care settings…," will allow the device to be marketed to additional care...
AOTI announces US FDA 510(k)...